United States · FDA National Drug Code directory
REXTOVY
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 76329-3669_25c8bc5f-61d9-4f9e-9ce5-99c9083e2caa
- Product NDC
- 76329-3669
- Form
- SPRAY
- Composition / generic term
- Naloxone Hydrochloride
- Labeler
- International Medication Systems, Ltd.
- Marketing category
- NDA
- Marketing start / end (source format)
- 20240507
- Source listing expiry
- 20261231
Source-listed ingredients
- NALOXONE HYDROCHLORIDE — 4 mg/.25mL
These values do not establish equivalence or a dose recommendation.
Packages
- 2 CONTAINER in 1 CONTAINER (76329-3669-2) / .25 mL in 1 CONTAINER · 76329-3669-2
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →